Institutional investors purchased a net $4.9 million shares of PTN during the quarter ended March 2017 and now own 15.18% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 814.5 Thousand shares of Palatin Technologies Inc
SABBY CAPITAL LLC Bought 353.2 Thousand shares of Palatin Technologies Inc